Bellevue Asset Management AG current holdings: USA Other Stocks
Bellevue Asset Management AG reported $0.20 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 54 positions, in its Form 13F for the quarter ended 2015-12-31; the largest are Celgene Corporation, Mylan Inc., Express Scripts Holding Company.
- Celgene Corporation: Country of operation —; Class COM; Shares 217,410; Value $26,037,000.
- Mylan Inc.: Country of operation —; Class COM; Shares 315,300; Value $17,048,000.
- Express Scripts Holding Company: Country of operation —; Class COM; Shares 124,000; Value $10,839,000.
- Endo International PLC: Country of operation —; Class SHS; Shares 171,000; Value $10,469,000.
Form 13F-HR as filed (SEC CIK 1642343): quarter ended 2015-12-31, filed 2016-02-12. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
Celgene Corporation
CUSIP 151020104 | | COM | 217,410 | $26,037,000 | 2015-12-31 | 2016-02-12 |
|---|
Mylan Inc.
CUSIP 628530107 | | COM | 315,300 | $17,048,000 | 2015-12-31 | 2016-02-12 |
|---|
Express Scripts Holding Company
CUSIP 30219G108 | | COM | 124,000 | $10,839,000 | 2015-12-31 | 2016-02-12 |
|---|
Endo International PLC
CUSIP G30401106 | | SHS | 171,000 | $10,469,000 | 2015-12-31 | 2016-02-12 |
|---|
Auris Medical Holding AG
CUSIP H03579101 | | COM | 2,169,625 | $10,414,000 | 2015-12-31 | 2016-02-12 |
|---|
Alexion Pharmaceuticals, Inc.
CUSIP 015351109 | | COM | 49,400 | $9,423,000 | 2015-12-31 | 2016-02-12 |
|---|
St. Jude Medical, Inc.
CUSIP 790849103 | | COM | 122,000 | $7,536,000 | 2015-12-31 | 2016-02-12 |
|---|
Cigna Corporation
CUSIP 125509109 | | COM | 48,000 | $7,024,000 | 2015-12-31 | 2016-02-12 |
|---|
Insys Therapeutics, Inc.
CUSIP 45824V209 | | COM NEW | 232,000 | $6,642,000 | 2015-12-31 | 2016-02-12 |
|---|
Aetna Inc.
CUSIP 00817Y108 | | COM | 53,000 | $5,730,000 | 2015-12-31 | 2016-02-12 |
|---|
Horizon Pharma plc
CUSIP G4617B105 | | SHS | 245,000 | $5,309,000 | 2015-12-31 | 2016-02-12 |
|---|
C.R. Bard, Inc.
CUSIP 067383109 | | COM | 27,000 | $5,115,000 | 2015-12-31 | 2016-02-12 |
|---|
Mallinckrodt public limited company
CUSIP G5785G107 | | SHS | 68,000 | $5,075,000 | 2015-12-31 | 2016-02-12 |
|---|
Intersect Ent, Inc.
CUSIP 46071F103 | | COM | 225,000 | $5,063,000 | 2015-12-31 | 2016-02-12 |
|---|
Achillion Pharmaceuticals, Inc.
CUSIP 00448Q201 | | COM | 420,000 | $4,532,000 | 2015-12-31 | 2016-02-12 |
|---|
Lannett Inc.
CUSIP 516012101 | | COM | 107,480 | $4,312,000 | 2015-12-31 | 2016-02-12 |
|---|
Nektar Therapeutics
CUSIP 640268108 | United States | COM | 216,000 | $3,640,000 | 2015-12-31 | 2016-02-12 |
|---|
Cerner Corporation
CUSIP 156782104 | | COM | 60,000 | $3,610,000 | 2015-12-31 | 2016-02-12 |
|---|
Novadaq Technologies Inc.
CUSIP 66987G102 | | COM | 250,000 | $3,185,000 | 2015-12-31 | 2016-02-12 |
|---|
ARIAD Pharmaceuticals, Inc.
CUSIP 04033A100 | | COM | 495,000 | $3,094,000 | 2015-12-31 | 2016-02-12 |
|---|
Seattle Genetics, Inc.
CUSIP 812578102 | | COM | 68,000 | $3,052,000 | 2015-12-31 | 2016-02-12 |
|---|
Medivation, Inc.
CUSIP 58501N101 | | COM | 63,000 | $3,045,000 | 2015-12-31 | 2016-02-12 |
|---|
Varian Medical Systems, Inc.
CUSIP 92220P105 | | COM | 37,000 | $2,990,000 | 2015-12-31 | 2016-02-12 |
|---|
Novavax, Inc.
CUSIP 670002104 | | COM | 325,000 | $2,727,000 | 2015-12-31 | 2016-02-12 |
|---|
Qiagen NV
CUSIP N72482107 | | REG SHS | 91,500 | $2,530,000 | 2015-12-31 | 2016-02-12 |
|---|
Celldex Therapeutics, Inc.
CUSIP 15117B103 | | COM | 160,000 | $2,509,000 | 2015-12-31 | 2016-02-12 |
|---|
Cooper Companies Inc.
CUSIP 216648402 | United States | COM NEW | 18,500 | $2,483,000 | 2015-12-31 | 2016-02-12 |
|---|
Radius Health Inc.
CUSIP 750469207 | | COM NEW | 40,000 | $2,462,000 | 2015-12-31 | 2016-02-12 |
|---|
Nuvasive, Inc.
CUSIP 670704105 | United States | COM | 45,000 | $2,435,000 | 2015-12-31 | 2016-02-12 |
|---|
Zeltiq Aesthetics Inc.
CUSIP 98933Q108 | | COM | 75,000 | $2,140,000 | 2015-12-31 | 2016-02-12 |
|---|
Intercept Pharmaceuticals, Inc.
CUSIP 45845P108 | United States | COM | 13,500 | $2,016,000 | 2015-12-31 | 2016-02-12 |
|---|
Bluebird Bio, Inc.
CUSIP 09609G100 | United States | COM | 29,000 | $1,862,000 | 2015-12-31 | 2016-02-12 |
|---|
Clovis Oncology, Inc.
CUSIP 189464100 | | COM | 52,500 | $1,838,000 | 2015-12-31 | 2016-02-12 |
|---|
Stericycle, Inc.
CUSIP 858912108 | United States | COM | 15,000 | $1,809,000 | 2015-12-31 | 2016-02-12 |
|---|
Inovio Pharmaceuticals, Inc.
CUSIP 45773H201 | United States | COM NEW | 265,000 | $1,781,000 | 2015-12-31 | 2016-02-12 |
|---|
Wright Medical Group Inc.
CUSIP N96617118 | | ORD SHS 0.03 PAR | 70,309 | $1,700,000 | 2015-12-31 | 2016-02-12 |
|---|
Juno Therapeutics, Inc.
CUSIP 48205A109 | | COM | 37,000 | $1,627,000 | 2015-12-31 | 2016-02-12 |
|---|
WellCare Health Plans, Inc.
CUSIP 94946T106 | | COM | 20,000 | $1,564,000 | 2015-12-31 | 2016-02-12 |
|---|
Laboratory Corporation of America Holdings
CUSIP 50540R409 | United States | COM NEW | 10,000 | $1,236,000 | 2015-12-31 | 2016-02-12 |
|---|
Alder Biopharmaceuticals Inc.
CUSIP 014339105 | | COM | 33,000 | $1,090,000 | 2015-12-31 | 2016-02-12 |
|---|
Kite Pharma, Inc.
CUSIP 49803L109 | | COM | 14,000 | $863,000 | 2015-12-31 | 2016-02-12 |
|---|
Affymetrix, Inc.
CUSIP 00826T108 | | COM | 80,000 | $807,000 | 2015-12-31 | 2016-02-12 |
|---|
Impax Laboratories, Inc.
CUSIP 45256B101 | | COM | 18,000 | $770,000 | 2015-12-31 | 2016-02-12 |
|---|
Team Health Holdings Inc.
CUSIP 87817A107 | | COM | 15,000 | $658,000 | 2015-12-31 | 2016-02-12 |
|---|
Juniper Pharmaceuticals Inc.
CUSIP 48203L107 | | COM | 50,000 | $515,000 | 2015-12-31 | 2016-02-12 |
|---|
Cadiovascular Systems Inc.
CUSIP 141619106 | | COM | 30,000 | $454,000 | 2015-12-31 | 2016-02-12 |
|---|
MannKind Corporation
CUSIP 56400P201 | | COM | 300,000 | $435,000 | 2015-12-31 | 2016-02-12 |
|---|
Immunomedics, Inc.
CUSIP 45253H101 | United States | COM | 30,000 | $407,000 | 2015-12-31 | 2016-02-12 |
|---|
Endocyte, Inc.
CUSIP 29269A102 | | COM | 100,000 | $401,000 | 2015-12-31 | 2016-02-12 |
|---|
XOMA Corporation
CUSIP 98419J107 | | COM | 225,000 | $299,000 | 2015-12-31 | 2016-02-12 |
|---|
Heartware International, Inc.
CUSIP 422368100 | | COM | 5,000 | $252,000 | 2015-12-31 | 2016-02-12 |
|---|
Tetraphase Pharmaceuticals, Inc.
CUSIP 88165N105 | | COM | 22,000 | $221,000 | 2015-12-31 | 2016-02-12 |
|---|
Celladon Corporation
CUSIP 15117E107 | | COM | 50,000 | $74,000 | 2015-12-31 | 2016-02-12 |
|---|
Asterias Biotherapeutics, Inc.
CUSIP 04624N107 | | COM SER A | 1,875 | $7,000 | 2015-12-31 | 2016-02-12 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |